Compare iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ Inv Grade Corporate Bond ETF vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $103.61 (market cap $29.10B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: iShares iBoxx $ Inv Grade Corporate Bond ETF is far larger — about 2.7× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares iBoxx $ Inv Grade Corporate Bond ETF for 126 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| LQD | RDY | |
|---|---|---|
Market Cap | $29.10B | $10.61B |
Volume | 33,185,388 | 3,738,869 |
Sector | Fixed Income | Health |
52-Week High | $112.91 | $15.38 |
52-Week Low | $101.83 | $11.38 |
Typical Hold Time | 126 Days | 0 Days |
Enterprise Value | — | $10.51B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LQD trades at $102.55, showing minimal daily movement with a slight decline of -0.03%. The ETF faces bearish technical signals across multiple indicators while maintaining regular dividend distributions. Recent news highlights significant short interest growth of 53.1% in September 2026 and unusual options activity, reflecting heightened market uncertainty amid rising bond yields and geopolitical tensions affecting corporate debt markets.
The investment-grade corporate bond ETF faces headwinds from rising Treasury yields and increased borrowing costs for corporations. While the 4.8% yield provides income appeal, the bearish technical outlook and growing short interest suggest near-term pressure. Key risks include further Fed rate hikes and economic slowdown impacting corporate credit quality.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
